Division of Health Services Research, Department of Psychiatry, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.
J Pain Symptom Manage. 2010 Aug;40(2):279-89. doi: 10.1016/j.jpainsymman.2010.01.012. Epub 2010 Jun 25.
CONTEXT: Although opioids are increasingly used for chronic noncancer pain (CNCP), we know little about opioid dosing patterns among individuals with CNCP in usual care settings, and how these are changing over time. OBJECTIVES: To investigate the distribution of mean daily dose and mean days supply among patients with CNCP in two disparate populations, one national and commercially insured population (HealthCore) and one state based and publicly insured (Arkansas Medicaid), for years 2000 and 2005. METHODS: For individuals with any opioid use, we calculated the distribution of mean daily dose (in milligram morphine equivalents), mean days supply in a year, mean annual dose, and patient characteristics associated with heavy utilizers of opioids. RESULTS: Between 2000 and 2005, across all percentiles, there was little change in the mean daily opioid dose. In HealthCore, mean days supply increased most rapidly at the top end of the days supply distribution, whereas in Arkansas Medicaid, the greatest increases were near the median of days supply. In HealthCore, the top 5% of users accounted for 70% of total use (measured in milligram morphine equivalents), and the top 5% of Arkansas Medicaid users accounted for 48% of total use. The likelihood of heavy opioid utilization was increased among individuals with multiple pain conditions, and in HealthCore, among those with mental health and substance use disorders. CONCLUSION: Opioid use is heavily concentrated among a small percent of patients. The characteristics of these high utilizers need to be further established, and the benefits and risks of their treatment evaluated.
背景:尽管阿片类药物越来越多地用于慢性非癌痛(CNCP),但我们对常规医疗环境中 CNCP 患者的阿片类药物剂量模式知之甚少,也不知道这些模式随时间的变化情况。 目的:在两个不同的人群中,即全国性商业保险人群(HealthCore)和州级公共保险人群(阿肯色州医疗补助)中,调查 2000 年和 2005 年 CNCP 患者的平均日剂量和平均年供应天数的分布情况。 方法:对于任何阿片类药物使用者,我们计算了平均日剂量(以吗啡等效毫克数表示)、一年中平均供应天数、平均年剂量的分布情况,以及与阿片类药物大量使用者相关的患者特征。 结果:在 2000 年至 2005 年间,所有百分位的平均阿片类药物日剂量变化不大。在 HealthCore 中,在供应天数分布的顶端,平均供应天数增加最快,而在阿肯色州医疗补助中,最大的增加则接近供应天数的中位数。在 HealthCore 中,前 5%的使用者占总用量(以吗啡等效毫克数表示)的 70%,而前 5%的阿肯色州医疗补助使用者占总用量的 48%。在 HealthCore 中,有多种疼痛状况的个体以及有精神健康和物质使用障碍的个体,其大量使用阿片类药物的可能性增加。 结论:阿片类药物的使用高度集中在一小部分患者中。这些高用量患者的特征需要进一步确定,并评估其治疗的益处和风险。
J Pain Symptom Manage. 2010-6-25
Drug Alcohol Depend. 2010-7-14
Gen Hosp Psychiatry. 2011-5-31
Pharmacoepidemiol Drug Saf. 2021-4
J Manag Care Spec Pharm. 2020-11
Int J Environ Res Public Health. 2021-12-20
Addict Health. 2019-10
J Pain Symptom Manage. 2008-9
Pharmacoepidemiol Drug Saf. 2007-8
Prim Care Companion J Clin Psychiatry. 2005